2/27
07:34 pm
engn
enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference [Yahoo! Finance]
Low
Report
enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference [Yahoo! Finance]
2/20
08:00 am
engn
enGene to Participate in Upcoming Investor Conferences
Low
Report
enGene to Participate in Upcoming Investor Conferences
2/16
07:17 am
engn
Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN) [Yahoo! Finance]
Low
Report
Jefferies Sets a $28 PT for enGene Holdings Inc. (ENGN) [Yahoo! Finance]
2/4
08:00 am
engn
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Low
Report
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
2/2
06:03 am
engn
Both private equity firms who control a good portion of enGene Holdings Inc. (NASDAQ:ENGN) along with institutions must be dismayed after last week's 16% decrease [Yahoo! Finance]
Medium
Report
Both private equity firms who control a good portion of enGene Holdings Inc. (NASDAQ:ENGN) along with institutions must be dismayed after last week's 16% decrease [Yahoo! Finance]
1/30
07:00 am
engn
enGene (NASDAQ:ENGN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
enGene (NASDAQ:ENGN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
1/20
05:48 pm
engn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. [Yahoo! Finance]
Low
Report
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. [Yahoo! Finance]
1/20
05:35 pm
engn
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
Medium
Report
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
1/13
04:05 am
engn
enGene (NASDAQ:ENGN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
enGene (NASDAQ:ENGN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/5
07:03 am
engn
enGene (NASDAQ:ENGN) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
enGene (NASDAQ:ENGN) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
12/26
04:02 pm
engn
enGene Holdings: A Potential Oncology Entrant [Seeking Alpha]
Medium
Report
enGene Holdings: A Potential Oncology Entrant [Seeking Alpha]
12/22
04:11 pm
engn
enGene Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
enGene Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
12/22
04:03 pm
engn
enGene Reports Full Year 2025 Financial Results and Provides Business Update
Medium
Report
enGene Reports Full Year 2025 Financial Results and Provides Business Update